![](/img/cover-not-exists.png)
SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer
Robles-Zurita, José, Boyd, Kathleen A., Briggs, Andrew H., Iveson, Timothy, Kerr, Rachel S., Saunders, Mark P., Cassidy, Jim, Hollander, Niels Henrik, Tabernero, Josep, Segelov, Eva, Glimelius, Bengt,Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/s41416-018-0319-z
Date:
November, 2018
File:
PDF, 445 KB
english, 2018